The proteasome--an emerging therapeutic target in cancer
- PMID: 12826633
- DOI: 10.1056/NEJMp030092
The proteasome--an emerging therapeutic target in cancer
Comment on
-
A phase 2 study of bortezomib in relapsed, refractory myeloma.N Engl J Med. 2003 Jun 26;348(26):2609-17. doi: 10.1056/NEJMoa030288. N Engl J Med. 2003. PMID: 12826635 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical